Related Experiment Video

Updated: Aug 9, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

Genetic abnormalities responsible for dilated cardiomyopathy

J A Towbin1, N E Bowles

  • 1Baylor College of Medicine, Pediatric Cardiology, 1 Baylor Plaza, Room 333E, Houston, TX 77030, USA. jtowbin@bcm.tmc.edu

Current Cardiology Reports
|September 12, 2000
PubMed

Insights

Dilated cardiomyopathy (DCM) is often inherited, with genetic mutations affecting cytoskeletal proteins. Identifying all causative genes will improve diagnosis and treatment for this heart condition.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure, with over 30% of cases having a hereditary basis.
  • The genetic underpinnings of DCM are complex and involve mutations in genes responsible for cytoskeletal structure and function.

Purpose of the Study:

  • To elucidate the genetic mechanisms contributing to dilated cardiomyopathy.
  • To identify novel genes associated with inherited DCM and understand their functional impact on cardiomyocytes.

Main Methods:

  • Genetic analysis of patients diagnosed with dilated cardiomyopathy.
  • Identification and characterization of mutated genes encoding cytoskeletal proteins.

Main Results:

  • Multiple genes responsible for DCM have been identified, primarily encoding cytoskeletal or associated proteins.
  • Mutations in these genes lead to destabilization of the cardiomyocyte membrane or cytoskeleton, resulting in impaired cardiac function.

Conclusions:

  • The identified genes contribute to DCM through mechanical instability or altered force transduction.
  • Comprehensive identification of all DCM-associated genes (genetic heterogeneity) is crucial for advancing diagnostic and therapeutic strategies.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Concept Videos

Mutations01:39

Mutations

Overview
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...